OXFORD, England, May 18, 2022 /PRNewswire/ -- Sitryx Therapeutics Ltd (the "Company"), a biopharmaceutical company pioneering the field of immunometabolism, today announced that company management will be participating at the Wells Fargo Virtual Private Company Biotech Symposium event on...
Sitryx is an England-based biopharmaceutical company that researches and develops immune cell metabolism therapies for the treatment of chronic autoimmune diseases and cancer.